Vaccine Market
To hear Novartis Vaccines & Diagnostics' head of technical ops tell it, fear was the enemy when Novartis swept into its newly acquired vaccine company, Chiron. And conquering that fear was what allowed the Swiss drugmaker's vaccines unit to deliver H1N1 flu vaccine quickly--and globally--during last year's pandemic. Report
Intercell has won approval from Swiss officials for Ixiaro, a vaccine for Japanese Encephalitis. Story
An epidemic of whooping cough has broken out in California, spurring a statewide effort to get children immunized against an illness that has killed five people so far this year. Report
Vaccine Research
Switzerland's Cytos has inked a flu vaccine development deal with Singapore's Agency for Science, Technology and Research, or A*STAR. They'll collaborate on a new seasonal flu vaccine that can be used in Asia. Story
Antigen Express has won a U.S. patent for an experimental therapeutic vaccine for patients with HER2-positive cancers. Report
Nabi Biopharmaceuticals reports that it has completed enrollment for its first late-stage trial of NicVAX, which is used to treat nicotine addiction. Release